6azl
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Structure of cetuximab with aminoheptanoic acid-linked N-carboxyethylarginine meditope variant== | ==Structure of cetuximab with aminoheptanoic acid-linked N-carboxyethylarginine meditope variant== | ||
| - | <StructureSection load='6azl' size='340' side='right' caption='[[6azl]], [[Resolution|resolution]] 2.48Å' scene=''> | + | <StructureSection load='6azl' size='340' side='right'caption='[[6azl]], [[Resolution|resolution]] 2.48Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[6azl]] is a 6 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6AZL OCA]. For a <b>guided tour on the structure components</b> use [http:// | + | <table><tr><td colspan='2'>[[6azl]] is a 6 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6AZL OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6AZL FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> |
<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=011:7-AMINOHEPTANOIC+ACID'>011</scene>, <scene name='pdbligand=C67:'>C67</scene></td></tr> | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=011:7-AMINOHEPTANOIC+ACID'>011</scene>, <scene name='pdbligand=C67:'>C67</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5id0|5id0]], [[6au5|6au5]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5id0|5id0]], [[6au5|6au5]]</td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http:// | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6azl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6azl OCA], [http://pdbe.org/6azl PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6azl RCSB], [http://www.ebi.ac.uk/pdbsum/6azl PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6azl ProSAT]</span></td></tr> |
</table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
| Line 22: | Line 22: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
[[Category: Bzymek, K P]] | [[Category: Bzymek, K P]] | ||
[[Category: Williams, J C]] | [[Category: Williams, J C]] | ||
Revision as of 21:34, 28 October 2020
Structure of cetuximab with aminoheptanoic acid-linked N-carboxyethylarginine meditope variant
| |||||||||||
